Agmatine Reverses Sub‐chronic Stress induced Nod‐like Receptor Protein 3 (NLRP3) Activation and Cytokine Response in Rats. Issue 4 (10th May 2016)
- Record Type:
- Journal Article
- Title:
- Agmatine Reverses Sub‐chronic Stress induced Nod‐like Receptor Protein 3 (NLRP3) Activation and Cytokine Response in Rats. Issue 4 (10th May 2016)
- Main Title:
- Agmatine Reverses Sub‐chronic Stress induced Nod‐like Receptor Protein 3 (NLRP3) Activation and Cytokine Response in Rats
- Authors:
- Sahin, Ceren
Albayrak, Ozgur
Akdeniz, Tuğba F.
Akbulut, Zeynep
Yanikkaya Demirel, Gulderen
Aricioglu, Feyza - Abstract:
- Abstract: The activation of Nod‐like receptor protein 3 (NLRP3) has lately been implicated in stress and depression as an initiator mechanism required for the production of interleukin (IL)‐1β and IL‐18. Agmatine, an endogenous polyamine widely distributed in mammalian brain, is a novel neurotransmitter/neuromodulator, with antistress, anxiolytic and antidepressant‐like effects. In this study, we examined the effect of exogenously administered agmatine on NLRP3 inflammasome pathway/cytokine responses in rats exposed to restraint stress for 7 days. The rats were divided into three groups: stress, stress+agmatine (40 mg/kg; i.p.) and control groups. Agmatine significantly down‐regulated the gene expressions of all stress‐induced NLRP3 inflammasome components (NLRP3, NF‐κB, PYCARD, caspase‐1, IL‐1β and IL‐18) in the hippocampus and prefrontal cortex (PFC) and reduced pro‐inflammatory cytokine levels not only in both brain regions, but also in serum. Stress‐reduced levels of IL‐4 and IL‐10, two major anti‐inflammatory cytokines, were restored back to normal by agmatine treatment in the PFC. The findings of the present study suggest that stress‐activated NLRP3 inflammasome and cytokine responses are reversed by an acute administration of agmatine. Whether antidepressant‐like effect of agmatine can somehow, at least partially, be mediated by the inhibition of NLRP3 inflammasome cascade and relevant inflammatory responses requires further studies in animal models of depression.
- Is Part Of:
- Basic & clinical pharmacology & toxicology. Volume 119:Issue 4(2016)
- Journal:
- Basic & clinical pharmacology & toxicology
- Issue:
- Volume 119:Issue 4(2016)
- Issue Display:
- Volume 119, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 119
- Issue:
- 4
- Issue Sort Value:
- 2016-0119-0004-0000
- Page Start:
- 367
- Page End:
- 375
- Publication Date:
- 2016-05-10
- Subjects:
- Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology, Clinical -- Periodicals
Computer network resources
Electronic journals
615.1 - Journal URLs:
- http://firstsearch.oclc.org/journal=1742-7835;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-7843 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=pto ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcpt.12604 ↗
- Languages:
- English
- ISSNs:
- 1742-7835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1863.914250
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2092.xml